Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autopsy-proven demyelination associated with infliximab treatment.
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
Deep morphea induced by interferon-β1b injection.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
Postural control, falls and fear of falling in people with multiple sclerosis without mobility aids.
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study.
Multiple sclerosis in Saudi Arabia: Anxiety, depression and suicidality.
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.
Re: S Shahrbanian, M Auais, P Duquette, K Anderson, NE Mayo. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18(5):e94-e100.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
P2X7 Receptor as a Therapeutic Target.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
Effects of Tysabri over 12 months on multiple sclerosis (MS) related fatigue in patients with relapsing remitting multiple sclerosis (RRMS) (TYNERGY)
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Correlation between Magnetic Resonance Imaging Findings and Pathological Observations in Tumefactive Multiple Sclerosis.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Microglia, physiology and behavior: A brief commentary.
Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Pages
« first
‹ previous
…
671
672
673
674
675
676
677
678
679
…
next ›
last »